New device to control combined lingual and palatal myoclonus.
Lingual myoclonus is a poorly understood disorder that may occur in isolation or combined with palatal myoclonus. In this report, we present the case history of a 21-year-old patient with a therapy-resistant essential lingual and palatal myoclonus where a simple dental device was able to control symptoms. The use of this device will be highlighted and compared to previously described methods. Cases of previously recorded lingual and palatal myoclonus will be reviewed and compared to the case of our patient.
Mondria
Tjeerd
T
Department of Neurology, Erasmus Medical Centre Rotterdam, The Netherlands. t.mondria@erasmusmc.nl
de Gier
Henriëtte H W
HH
Boon
Agnita J W
AJ
D000328:Adult; D000588:Amines / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005133:Eye Movements / Q000502:physiology; D000077206:Gabapentin; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009207:Myoclonus / Q000175:diagnosis / Q000503:physiopathology* / Q000517:prevention & control*; D013674:Technology, Dental / Q000295:instrumentation*; D014059:Tongue / Q000503:physiopathology*; D014635:Valproic Acid / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D002998:Clonazepam; D014635:Valproic Acid; D000077206:Gabapentin